Deep Venous Disease Treatment Devices Market – A Global and Regional Analysis: Focus on Product, End User and Country Analysis – Analysis and Forecast, 2023-2032

Table of Contents

1 Markets 1.1 Global Market Outlook 1.1.1 Product Definition 1.1.2 Inclusion and Exclusion Criteria 1.1.3 Key Findings 1.1.4 Global Market Scenario 1.1.4.1 Realistic Growth Scenario 1.1.4.2 Optimistic Scenario 1.1.4.3 Pessimistic Scenario 1.2 Industry Outlook 1.2.1 Key Trends 1.2.1.1 Rise in the Number of Regulatory Approvals and Legal Activities of Products and Devices for Deep Venous Disease Treatment 1.2.1.2 Upsurge in the Use of Non-Invasive and Minimally Invasive Techniques to Treat and Prevent Deep Venous Diseases 1.2.2 Patent Analysis 1.2.2.1 Awaited Technological Developments 1.2.2.2 Patent Filing Trend (by Year) 1.2.2.3 Patent Filing Trend (by Region) 1.2.3 Product Benchmarking 1.2.4 Ongoing Clinical Trial Analysis 1.2.5 Product Pipeline 1.2.6 Regulatory Scenario 1.2.6.1 U.S. Food and Drugs Administration (U.S. FDA) 1.2.6.2 European Medicines Agency (EMA) 1.2.6.3 National Medical Products Administration (NMPA) 1.2.6.4 Pharmaceuticals and Medical Devices Agency (PMDA) 1.3 Impact of COVID-19 on Deep Venous Disease Treatment Devices Market 1.3.1 Impact on Deep Venous Disease Treatment Devices 1.3.2 Impact on New Product Launches by Market Players 1.3.3 Impact on Market Size 1.3.3.1 Pre-COVID-19 Phase 1.3.3.2 During COVID-19 Phase 1.3.3.3 Post-COVID-19 Phase 1.4 Business Dynamics 1.4.1 Impact Analysis 1.4.2 Business Drivers 1.4.2.1 Upsurge in Incidence of Deep Vein Diseases Leading to Increased Demand for Treatment Devices 1.4.2.2 Increasing Awareness of Preventative Devices Leading to the Growth of Deep Venous Disease Devices in the Market 1.4.2.3 Rise in Diagnosis of Deep Venous Diseases in Hospitals Leading to Increased Use of Treatment Devices 1.4.3 Business Restraints 1.4.3.1 Rise in Drug-Based Treatment for Deep Venous Diseases Hindering the Adoption of Surgical Devices 1.4.3.2 Lack of Skilled Professionals Performing Vascular Surgery Expected to Hinder the Market of Surgical Treatment Devices 1.4.4 Business Opportunities 1.4.4.1 Development of Patient Specific Vascular Stents 1.4.4.2 Development of Advanced Intermittent Pneumatic Compression (IPC) Device for Prophylaxis of Diseases. 2 Global Deep Venous Disease Treatment Devices Market (by Product) 2.1 Opportunity Assessment 2.2 Growth-Share Matrix 2.3 Thrombectomy and Thrombolysis Device 2.3.1 Market Dynamics 2.3.2 Competitive Analysis 2.3.3 Market Size and Forecast 2.3.3.1 Thrombectomy and Thrombolysis Device (by Device) 2.4 Inferior Vena Cava (IVC) Filter 2.4.1 Market Dynamics 2.4.2 Competitive Analysis 2.4.3 Market Size and Forecast 2.4.3.1 Inferior Vena Cava Filter (by Device) 2.5 Peripheral Vascular Stent 2.5.1 Market Dynamics 2.5.2 Competitive Analysis 2.5.3 Market Size and Forecast 2.5.3.1 Peripheral Vascular Stent (by Type) 2.6 PTA Balloon Catheter 2.6.1 Market Dynamics 2.6.2 Competitive Analysis 2.6.3 Market Size and Forecast 2.6.3.1 PTA Balloon Catheter (by Material) 2.7 Accessory Device 2.7.1 Competitive Analysis 2.7.2 Market Size and Forecast 2.7.2.1 Accessory Device (by Type) 2.8 Compression Device/Stockings 2.8.1 Market Dynamics 2.8.2 Competitive Analysis 2.8.3 Market Size and Forecast 3 Global Deep Venous Disease Treatment Devices Market (by End User) 3.1 Opportunity Assessment 3.2 Growth-Share Matrix 3.3 Hospitals and Clinics 3.4 Ambulatory Surgery Centers 3.5 Home-Care 4 Region 4.1 North America Deep Venous Disease Treatment Devices Market 4.1.1 Key Findings and Opportunity Assessment 4.1.2 Market Dynamics 4.1.2.1 Impact Analysis 4.1.3 Market Sizing and Forecast 4.1.3.1 North America Deep Venous Disease Treatment Devices Market (by Product Type) 4.1.3.2 North America Deep Venous Disease Treatment Devices Market (by End User) 4.1.3.3 North America Deep Venous Disease Treatment Devices Market (by Country) 4.1.3.3.1 U.S. 4.1.3.3.1.1 U.S. Deep Venous Disease Treatment Devices Market (by Product Type) 4.1.3.3.1.2 U.S. Deep Venous Disease Treatment Devices Market (by End User) 4.1.3.3.2 Canada 4.1.3.3.2.1 Canada Deep Venous Disease Treatment Devices Market (by Product Type) 4.1.3.3.2.2 Canada Deep Venous Disease Treatment Devices Market (by End User) 4.2 Europe Deep Venous Disease Treatment Devices Market 4.2.1 Key Findings and Opportunity Assessment 4.2.2 Market Dynamics 4.2.2.1 Impact Analysis 4.2.3 Market Sizing and Forecast 4.2.3.1 Europe Deep Venous Disease Treatment Devices Market (by Product Type) 4.2.3.2 Europe Deep Venous Disease Treatment Devices Market (by End User) 4.2.3.3 Europe Deep Venous Disease Treatment Devices Market (by Country) 4.2.3.3.1 Germany 4.2.3.3.1.1 Germany Deep Venous Disease Treatment Devices Market (by Product Type) 4.2.3.3.1.2 Germany Deep Venous Disease Treatment Devices Market (by End User) 4.2.3.3.2 U.K. 4.2.3.3.2.1 U.K. Deep Venous Disease Treatment Devices Market (by Product Type) 4.2.3.3.2.2 U.K. Deep Venous Disease Treatment Devices Market (by End User) 4.2.3.3.3 France 4.2.3.3.3.1 France Deep Venous Disease Treatment Devices Market (by Product Type) 4.2.3.3.3.2 France Deep Venous Disease Treatment Devices Market (by End User) 4.2.3.3.4 Italy 4.2.3.3.4.1 Italy Deep Venous Disease Treatment Devices Market (by Product Type) 4.2.3.3.4.2 Italy Deep Venous Disease Treatment Devices Market (by End User) 4.2.3.3.5 Spain 4.2.3.3.5.1 Spain Deep Venous Disease Treatment Devices Market (by Product Type) 4.2.3.3.5.2 Spain Deep Venous Disease Treatment Devices Market (by End User) 4.2.3.3.6 Rest-of-Europe 4.2.3.3.6.1 Rest-of-Europe Deep Venous Disease Treatment Devices Market (by Product Type) 4.2.3.3.6.2 Rest-of-Europe Deep Venous Disease Treatment Devices Market (by End User) 4.3 Asia-Pacific Deep Venous Disease Treatment Devices Market 4.3.1 Key Findings and Opportunity Assessment 4.3.2 Market Dynamics 4.3.2.1 Impact Analysis 4.3.3 Market Sizing and Forecast 4.3.3.1 Asia-Pacific Deep Venous Disease Treatment Devices Market (by Product Type) 4.3.3.2 Asia-Pacific Deep Venous Disease Treatment Devices Market (by End User) 4.3.3.3 Asia-Pacific Deep Venous Disease Treatment Devices Market (by Country) 4.3.3.3.1 Japan 4.3.3.3.1.1 Japan Deep Venous Disease Treatment Devices Market (by Product Type) 4.3.3.3.1.2 Japan Deep Venous Disease Treatment Devices Market (by End User) 4.3.3.3.2 China 4.3.3.3.2.1 China Deep Venous Disease Treatment Devices Market (by Product Type) 4.3.3.3.2.2 China Deep Venous Disease Treatment Devices Market (by End User) 4.3.3.3.3 India 4.3.3.3.3.1 India Deep Venous Disease Treatment Devices Market (by Product Type) 4.3.3.3.3.2 India Deep Venous Disease Treatment Devices Market (by End User) 4.3.3.3.4 Australia 4.3.3.3.4.1 Australia Deep Venous Disease Treatment Devices Market (by Product Type) 4.3.3.3.4.2 Australia Deep Venous Disease Treatment Devices Market (by End User) 4.3.3.3.5 South Korea 4.3.3.3.5.1 South Korea Deep Venous Disease Treatment Devices Market (by Product Type) 4.3.3.3.5.2 South Korea Deep Venous Disease Treatment Devices Market (by End User) 4.3.3.3.6 Rest-of-Asia-Pacific 4.3.3.3.6.1 Rest-of-Asia-Pacific Deep Venous Disease Treatment Devices Market (by Product Type) 4.3.3.3.6.2 Rest-of-Asia-Pacific Deep Venous Disease Treatment Devices Market (by End User) 4.4 Rest-of-the-World Deep Venous Disease Treatment Devices Market 4.4.1 Key Findings and Opportunity Assessment 4.4.2 Market Dynamics 4.4.2.1 Impact Analysis 4.4.3 Market Sizing and Forecast 4.4.3.1 Rest-of-the-World Deep Venous Disease Treatment Devices Market (by Product Type) 4.4.3.2 Rest-of-the-World Deep Venous Disease Treatment Devices Market (by End User) 4.4.3.3 Rest-of-the-World Deep Venous Disease Treatment Devices Market (by Country) 4.4.3.3.1 Brazil 4.4.3.3.1.1 Brazil Deep Venous Disease Treatment Devices Market (by Product Type) 4.4.3.3.1.2 Brazil Deep Venous Disease Treatment Devices Market (by End User) 4.4.3.3.2 South Africa 4.4.3.3.2.1 South Africa Deep Venous Disease Treatment Devices Market (by Product Type) 4.4.3.3.2.2 South Africa Deep Venous Disease Treatment Devices Market (by End User) 4.4.3.3.3 Rest-of-Rest-of-the-World 4.4.3.3.3.1 Rest-of-Rest-of-the-World Deep Venous Disease Treatment Devices Market (by Product Type) 4.4.3.3.3.2 Rest-of-Rest-of-the-World Deep Venous Disease Treatment Devices Market (by End User) 5 Markets - Competitive Benchmarking & Company Profiles 5.1 Competitive Landscape 5.1.1 Key Strategies and Developments 5.1.1.1 Regulatory and Legal Activities 5.1.1.2 Partnerships, Alliances, and Business Expansions 5.1.1.3 New Offerings 5.1.1.4 Mergers and Acquisitions 5.1.1.5 Funding Activities 5.1.2 Key Development Analysis (Heat Map) 5.2 Company Profiles 5.2.1 Abbott Laboratories 5.2.1.1 Company Overview 5.2.1.2 Role of Abbott Laboratories in the Global Deep Venous Disease Treatment Devices Market 5.2.1.3 Product Portfolio 5.2.1.4 Financials 5.2.1.5 Recent Developments 5.2.1.6 Analyst Perspectives 5.2.2 AndraTec GmbH 5.2.2.1 Company Overview 5.2.2.2 Role of AndraTec GmbH in the Deep Venous Disease Treatment Devices Market 5.2.2.3 Product Portfolio 5.2.2.4 Recent Developments 5.2.2.5 Analyst Perception 5.2.3 AngioDynamics, Inc. 5.2.3.1 Company Overview 5.2.3.2 Role of AngioDynamics, Inc. in the Deep Venous Disease Treatment Devices Market 5.2.3.3 Product Portfolio 5.2.3.4 Financials 5.2.3.5 Recent Developments 5.2.3.6 Analyst Perception 5.2.4 Boston Scientific Corporation 5.2.4.1 Company Overview 5.2.4.2 Role of Boston Scientific Corporation in the Deep Venous Disease Treatment Devices Market 5.2.4.3 Product Portfolio 5.2.4.4 Financials 5.2.4.5 Recent Developments 5.2.4.6 Analyst Perception 5.2.5 Cardinal Health 5.2.5.1 Company Overview 5.2.5.2 Role of Cardinal Health in the Deep Venous Disease Treatment Devices Market 5.2.5.3 Product Portfolio 5.2.5.4 Financials 5.2.5.5 Analyst Perception 5.2.6 Cook Group 5.2.6.1 Company Overview 5.2.6.2 Role of Cook Group in the Deep Venous Disease Treatment Devices Market 5.2.6.3 Product Portfolio 5.2.6.4 Recent Developments 5.2.6.5 Analyst Perception 5.2.7 Innova Vascular, Inc. 5.2.7.1 Company Overview 5.2.7.2 Role of Innova Vascular, Inc. in the Deep Venous Disease Treatment Devices Market 5.2.7.3 Recent Developments 5.2.7.4 Analyst Perception 5.2.8 Koninklijke Philips N.V. 5.2.8.1 Company Overview 5.2.8.2 Role of Koninklijke Philips N.V. in the Deep Venous Disease Treatment Devices Market 5.2.8.3 Product Portfolio 5.2.8.4 Financials 5.2.8.5 Recent Developments 5.2.8.6 Analyst Perception 5.2.9 Medtronic plc 5.2.9.1 Company Overview 5.2.9.2 Role of Medtronic plc in the Deep Venous Disease Treatment Devices Market 5.2.9.3 Product Portfolio 5.2.9.4 Financials 5.2.9.5 Recent Developments 5.2.9.6 Analyst Perception 5.2.10 Nipro Corporation 5.2.10.1 Company Overview 5.2.10.2 Role of Nipro Corporation in the Deep Venous Disease Treatment Devices Market 5.2.10.3 Product Portfolio 5.2.10.4 Financials 5.2.10.5 Recent Developments 5.2.10.6 Analyst Perception 5.2.11 Penumbra, Inc. 5.2.11.1 Company Overview 5.2.11.2 Role of Penumbra, Inc. in the Deep Venous Disease Treatment Devices Market 5.2.11.3 Product Portfolio 5.2.11.4 Financials 5.2.11.5 Recent Developments 5.2.11.6 Analyst Perception 5.2.12 Stryker Corporation 5.2.12.1 Company Overview 5.2.12.2 Role of Stryker Corporation in the Deep Venous Disease Treatment Devices Market 5.2.12.3 Product Portfolio 5.2.12.4 Financials 5.2.12.5 Analyst Perception 5.2.13 Surmodics, Inc. (Vetex Medical Ltd.) 5.2.13.1 Company Overview 5.2.13.2 Role of Surmodics, Inc. in the Deep Venous Disease Treatment Devices Market 5.2.13.3 Product Portfolio 5.2.13.4 Financials 5.2.13.5 Recent Developments 5.2.13.6 Analyst Perception 5.2.14 Teleflex Incorporated 5.2.14.1 Company Overview 5.2.14.2 Role of Teleflex Incorporated in the Deep Venous Disease Treatment Devices Market 5.2.14.3 Product Portfolio 5.2.14.4 Financials 5.2.14.5 Recent Development 5.2.14.6 Analyst Perception 5.2.15 Terumo Corporation 5.2.15.1 Company Overview 5.2.15.2 Role of Terumo Corporation in the Deep Venous Disease Treatment Devices Market 5.2.15.3 Product Portfolio 5.2.15.4 Financials 5.2.15.5 Recent Developments 5.2.15.6 Analyst Perception List of Figures Figure 1: Global Deep Venous Disease Treatment Devices Market, Impact Analysis Figure 2: Global Deep Venous Disease Treatment Devices Market (by Product), Share (%), 2022 and 2032 Figure 3: Global Deep Venous Disease Treatment Devices Market (by Region), $Million, 2022 and 2032 Figure 4: Global Deep Venous Disease Treatment Devices Market Segmentation Figure 5: Global Deep Venous Disease Treatment Devices Market: Research Methodology Figure 6: Primary Research Methodology Figure 7: Bottom-Up Approach (Segment-Wise Analysis) Figure 8: Top-Down Approach (Segment-Wise Analysis) Figure 9: Global Deep Venous Disease Treatment Devices Market Size and Growth Potential (Realistic Scenario), $Million, 2020-2032 Figure 10: Global Deep Venous Disease Treatment Devices Market Size and Growth Potential (Optimistic Scenario), $Million, 2020-2032 Figure 11: Global Deep Venous Disease Treatment Devices Market Size and Growth Potential (Pessimistic/Conservative Scenario), $Million, 2020-2032 Figure 12: Regulatory and Legal Activities, January 2019-December 2022 Figure 13: Global Deep Venous Disease Treatment Devices Market, Patent Analysis (by Year), January 2018-December 2022 Figure 14: Global Deep Venous Disease Treatment Devices Market, Patent Analysis (by Country), January 2018-December 2022 Figure 15: Deep Venous Disease Treatment Devices (Ongoing Clinical Trials), by Interventions, 2022 Figure 16: Deep Venous Disease Treatment Devices (Ongoing Clinical Trials), by Company Figure 17: Global Deep Venous Disease Treatment Devices Market, Pre-COVID-19 Phase, $Million, 2020-2032 Figure 18: Global Deep Venous Disease Treatment Devices Market, Impact Analysis Figure 19: Global Deep Vein Thrombosis and Pulmoanry EmbolismIncidences, 2017-2021 Figure 20: Surgeries and Medical Procedures Considered to Increase the Risk of DVT Figure 21: FDA Approvals (Rivaroxaban, Apixaban, Dabigatran, Edoxaban, and Betrixaban Active Ingredients), 2017-2021 Figure 22: Global Deep Venous Disease Treatment Devices Market (by Product) Figure 23: Global Deep Venous Disease Treatment Devices Market, Incremental Opportunity (by Product), $Million, 2022-2032 Figure 24: Global Deep Venous Disease Treatment Devices Market, Growth-Share Matrix (by Product), 2022-2032 Figure 25: Global Deep Venous Disease Treatment Devices Market (Thrombectomy and Thrombolysis Device), Market Dynamics Figure 26: Global Deep Venous Disease Treatment Devices Market (Thrombectomy and Thrombolysis Device), $Million, 2020-2032 Figure 27: Global Deep Venous Disease Treatment Devices Market (Thrombectomy and Thrombolysis Device), by Device, $Million, 2020-2032 Figure 28: Global Deep Venous Disease Treatment Devices Market (IVC Filter), Market Dynamics Figure 29: Global Deep Venous Disease Treatment Devices Market (Inferior Vena Cava Filter), $Million, 2020-2032 Figure 30: Global Deep Venous Disease Treatment Devices Market (Inferior Vena Cava Filter), by Device, $Million, 2020-2032 Figure 31: Global Deep Venous Disease Treatment Devices Market (Peripheral Vascular Stent), Market Dynamics Figure 32: Global Deep Venous Disease Treatment Devices Market (Peripheral Vascular Stent), $Million, 2020-2032 Figure 33: Global Deep Venous Disease Treatment Devices Market (Peripheral Vascular Stent), by Type, $Million, 2020-2032 Figure 34: Global Deep Venous Disease Treatment Devices Market (PTA Balloon Catheter), Market Dynamics Figure 35: Global Deep Venous Disease Treatment Devices Market (PTA Balloon Catheter), $Million, 2020-2032 Figure 36: Global Deep Venous Disease Treatment Devices Market (PTA Balloon Catheter), by Material, $Million, 2020-2032 Figure 37: Global Deep Venous Disease Treatment Devices Market (Accessory Device), $Million, 2020-2032 Figure 38: Global Deep Venous Disease Treatment Devices Market (Accessory Device), by Type, $Million, 2020-2032 Figure 39: Global Deep Venous Disease Treatment Devices Market (Compression Device/Stockings), Market Dynamics Figure 40: Global Deep Venous Disease Treatment Devices Market (Compression Device/Stockings), $Million, 2020-2032 Figure 41: Global Deep Venous Disease Treatment Devices Market (by End User) Figure 42: Global Deep Venous Disease Treatment Devices Market Incremental Opportunity (by End User), $Million, 2022-2032 Figure 43: Global Deep Venous Disease Treatment Devices Market, Growth-Share Matrix (by End User), 2022-2032 Figure 44: Global Deep Venous Disease Treatment Devices Market (Hospitals and Clinics), $Million, 2020-2032 Figure 45: Global Deep Venous Disease Treatment Devices Market (Ambulatory Surgery Centers), $Million, 2020-2032 Figure 46: Global Deep Venous Disease Treatment Devices Market (Home-Care), $Million, 2020-2032 Figure 47: Global Deep Venous Disease Treatment Devices Market Share and CAGR (by Region), 2022 and 2023-2032 Figure 48: North America Deep Venous Disease Treatment Devices Market Incremental Opportunity (by Country), $Million, 2022-2032 Figure 49: North America Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 50: North America Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 51: North America Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 52: North America Deep Venous Disease Treatment Devices Market (by Country), Share (%), 2022 and 2032 Figure 53: Prevalence of Deep Vein Thrombosis (DVT) and Pulmonary Embolsim (PE) in the U.S., 2022 Figure 54: U.S. Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 55: U.S. Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 56: U.S. Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 57: Canada Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 58: Canada Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 59: Canada Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 60: Europe Deep Venous Disease Treatment Devices Market Incremental Opportunity (by Country), $Million, 2022-2032 Figure 61: Europe Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 62: Europe Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 63: Europe Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 64: Europe Deep Venous Disease Treatment Devices Market (by Country), Share (%), 2022 and 2032 Figure 65: Germany Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 66: Germany Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 67: Germany Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 68: U.K. Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 69: U.K. Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 70: U.K. Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 71: France Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 72: France Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 73: France Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 74: Italy Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 75: Italy Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 76: Italy Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 77: Spain Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 78: Spain Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 79: Spain Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 80: Rest-of-Europe Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 81: Rest-of-Europe Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 82: Rest-of-Europe Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 83: Asia-Pacific Deep Venous Disease Treatment Devices Market Incremental Opportunity (by Country), $Million, 2022-2032 Figure 84: Asia-Pacific Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 85: Asia-Pacific Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 86: Asia-Pacific Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 87: Asia-Pacific Deep Venous Disease Treatment Devices Market (by Country), Share (%), 2022 and 2032 Figure 88: Japan Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 89: Japan Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 90: Japan Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 91: China Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 92: China Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 93: China Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 94: India Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 95: India Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 96: India Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 97: Australia Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 98: Australia Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 99: Australia Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 100: South Korea Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 101: South Korea Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 102: South Korea Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 103: Rest-of-Asia-Pacific Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 104: Rest-of-Asia-Pacific Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 105: Rest-of-Asia-Pacific Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 106: Rest-of-the-World Deep Venous Disease Treatment Devices Market Incremental Opportunity (by Country), $Million, 2022-2032 Figure 107: Rest-of-the-World Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 108: Rest-of-the-World Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 109: Rest-of-the-World Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 110: Rest-of-the-World Deep Venous Disease Treatment Devices Market (by Country), Share (%), 2022 and 2032 Figure 111: Brazil Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 112: Brazil Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 113: Brazil Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 114: South Africa Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 115: South Africa Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 116: South Africa Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 117: Rest-of-Rest-of-the-World Deep Venous Disease Treatment Devices Market, $Million, 2020-2032 Figure 118: Rest-of-Rest-of-the-World America Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032 Figure 119: Rest-of-Rest-of-the-World Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032 Figure 120: Share of Key Developments and Strategies, January 2019-January 2023 Figure 121: Regulatory and Legal Activities (by Company), January 2019-January 2023 Figure 122: Partnerships, Alliances, and Business Expansions (by Company), January 2019-January 2023 Figure 123: New Offerings (by Company), January 2019-January 2023 Figure 124: Mergers and Acquisitions (by Company), January 2019-January 2023 Figure 125: Funding Activities (by Company), January 2019-January 2023 Figure 126: Key Development Analysis (Heat Map), January 2019-January 2023 Figure 127: Abbott Laboratories: Overall Product Portfolio Figure 128: Abbott Laboratories: Overall Financials, $Million, 2019-2021 Figure 129: Abbott Laboratories: Net Revenue (by Business Segment), $Million, 2019-2021 Figure 130: Abbott Laboratories: Net Revenue (by Region), $Million, 2019-2021 Figure 131: Abbott Laboratories: R&D Expenditure, $Million, 2019-2021 Figure 132: AndraTec GmbH: Overall Product Portfolio Figure 133: AngioDynamics, Inc.: Overall Product Portfolio Figure 134: AngioDynamics, Inc.: Overall Financials, $Million, 2020-2022 Figure 135: AngioDynamics, Inc.: Revenue (by Segment), $Million, 2020-2022 Figure 136: AngioDynamics, Inc.: Revenue (by Region), $Million, 2020-2022 Figure 137: AngioDynamics, Inc.: R&D Expense, $Million, 2020-2022 Figure 138: Boston Scientific Corporation: Overall Product Portfolio Figure 139: Boston Scientific Corporation: Overall Financials, $Million, 2019-2021 Figure 140: Boston Scientific Corporation: Revenue (by Segment), $Million, 2019-2021 Figure 141: Boston Scientific Corporation: R&D Expense, $Million, 2019-2021 Figure 142: Cardinal Health: Overall Product Portfolio Figure 143: Cardinal Health: Overall Financials, $Million, 2020-2022 Figure 144: Cardinal Health: Revenue (by Segment), $Million, 2020-2022 Figure 145: Cardinal Health: Revenue (by Region), $Million, 2020-2022 Figure 146: Cook Group: Overall Product Portfolio Figure 147: Koninklijke Philips N.V.: Product Portfolio Figure 148: Koninklijke Philips N.V.: Overall Financials, $Million, 2019-2021 Figure 149: Koninklijke Philips N.V.: Revenue (by Segment), $Million, 2019-2021 Figure 150: Koninklijke Philips N.V.: Revenue (by Region), $Million, 2019-2021 Figure 151: Koninklijke Philips N.V.: R&D Expenditure, $Million, 2019-2021 Figure 152: Medtronic plc: Overall Product Portfolio Figure 153: Medtronic plc: Overall Financials, $Million, 2020-2022 Figure 154: Medtronic plc: Revenue (by Segment), $Million, 2020-2022 Figure 155: Medtronic plc: Revenue (by Region), $Million 2020-2022 Figure 156: Medtronic plc: R&D Expense, $Million, 2020-2022 Figure 157: Nipro Corporation: Overall Product Portfolio Figure 158: Nipro Corporation: Overall Financials, $Million, 2020-2022 Figure 159: Nipro Corporation: Revenue (by Segment), $Million, 2020-2022 Figure 160: Nipro Corporation: R&D Expense, $Million, 2020-2022 Figure 161: Penumbra, Inc.: Overall Product Portfolio Figure 162: Penumbra, Inc.: Overall Financials, $Million, 2019-2021 Figure 163: Penumbra, Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 164: Penumbra, Inc.: Revenue (by Region), $Million 2019-2021 Figure 165: Penumbra, Inc.: R&D Expense, $Million, 2019-2021 Figure 166: Stryker Corporation: Overall Product Portfolio Figure 167: Stryker Corporation: Overall Financials, $Million, 2019-2021 Figure 168: Stryker Corporation: Revenue (by Segment), $Million, 2019-2021 Figure 169: Stryker Corporation: Subsegment Revenue (MedSurg and Neurotechnology), $Million 2019-2021 Figure 170: Stryker Corporation: Revenue (by Region), $Million 2019-2021 Figure 171: Stryker Corporation: R&D Expense, $Million, 2019-2021 Figure 172: Surmodics, Inc.: Overall Product Portfolio Figure 173: Surmodics, Inc.: Overall Financials, $Million, 2020-2022 Figure 174: Surmodics, Inc.: Revenue (by Segment), $Million, 2020-2022 Figure 175: Surmodics, Inc.: R&D Expense, $Million, 2020-2022 Figure 176: Teleflex Incorporated: Overall Product Portfolio Figure 177: Teleflex Incorporated: Overall Financials, $Million, 2019-2021 Figure 178: Teleflex Incorporated: Revenue (by Segment), $Million, 2019-2021 Figure 179: Teleflex Incorporated: Revenue (by Region), $Million 2019-2021 Figure 180: Teleflex Incorporated: R&D Expense, $Million, 2019-2021 Figure 181: Terumo Corporation: Overall Product Portfolio Figure 182: Terumo Corporation: Overall Financials, $Million, 2020-2022 Figure 183: Terumo Corporation: Revenue (by Segment), $Million, 2020-2022 Figure 184: Terumo Corporation: Revenue (by Region), $Million 2020-2022 List of Tables Table 1: Global Deep Venous Disease Treatment Devices Market, Quarterly Key Developments Analysis, January 2018-January 2023 Table 2: Key Questions Answered in the Report Table 3: Parameters for Realistic, Optimistic, and Pessimistic Growth Scenarios Table 4: Global Deep Venous Disease Treatment Devices Market, Product Benchmarking Table 5: Global Deep Venous Disease Treatment Devices Market, Pipeline Companies Table 6: Global Deep Venous Disease Treatment Devices (by Thrombectomy and Thrombolysis Device), Heat Map Table 7: Global Deep Venous Disease Treatment Devices (by IVC Filter), Heat Map Table 8: Global Deep Venous Disease Treatment Devices (by Peripheral Vascular Stent), Heat Map Table 9: Global Deep Venous Disease Treatment Devices (by PTA Balloon Catheter), Heat Map Table 10: Global Deep Venous Disease Treatment Devices (by Accessory Device), Heat Map Table 11: Global Deep Venous Disease Treatment Devices (by Compression Device/Stockings), Heat Map Table 12: North America Deep Venous Disease Treatment Devices Market, Impact Analysis Table 13: Recalls for Deep Venous Disease Treatment Devices by the U.S. Food and Drug Administration (FDA) Table 14: Europe Deep Venous Disease Treatment Devices Market, Impact Analysis Table 15: Asia-Pacific Deep Venous Disease Treatment Devices Market, Impact Analysis Table 16: Rest-of-the-World Deep Venous Disease Treatment Devices Market, Impact Analysis Table 17: Abbott Laboratories.: Key Products and Features Table 18: AndraTec GmbH: Key Products and Features Table 19: AngioDynamics, Inc.: Key Products and Features Table 20: Boston Scientific Corporation: Key Products and Features Table 21: Cardinal Health: Key Products and Features Table 22: Cook Group: Key Products and Features Table 23: Koninklijke Philips N.V.: Key Products and Features Table 24: Medtronic plc: Key Products and Features Table 25: Nipro Corporation: Key Products and Features Table 26: Penumbra, Inc.: Key Products and Features Table 27: Stryker Corporation: Key Products and Features Table 28: Surmodics, Inc.: Key Products and Features Table 29: Teleflex Incorporated: Key Products and Features Table 30: Terumo Corporation: Key Products and Features